Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroendocrine Tumors in Lung × lanreotide × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 13 Carcinoid Tumor 5 Serotonin Syndrome 2 Pituitary Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Acromegaly 2 Pheochromocytoma 1 Paraganglioma 1 Neuroendocrine Tumour With Carcinoid Symptoms 1 Neuroendocrine Tumors in Lung 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Growth Hormone-Secreting Pituitary Adenoma 1 Gigantism 1 Gastrointestinal Neoplasms 1 Flushing 1 Diarrhea 1 Carcinoma, Hepatocellular 1 Carcinoid Heart Disease 1 Adenoma, Islet Cell 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02683941 2022-07-06

SPINET

Ipsen

Phase 3 Terminated

77 enrolled 20 charts

Neuroendocrine Tumors in Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡